Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369583PMC
http://dx.doi.org/10.1016/j.ensci.2020.100254DOI Listing

Publication Analysis

Top Keywords

thromboembolic mechanism
4
mechanism bow
4
bow hunter's
4
hunter's stroke
4
stroke hemodynamic
4
hemodynamic evaluation
4
evaluation ultrasonography
4
ultrasonography head
4
head rotation
4
thromboembolic
1

Similar Publications

Background: Carotid web (CaW) is a rare fibromuscular dysplasia lesion at the carotid bifurcation linked to thromboembolic events in young patients. CaW-induced hemodynamic disturbances contribute to thrombosis, but the impact of CaW morphology on long-term thrombotic risk remains unclear.

Method: This study developed three-dimensional numerical models based on patient-specific carotid artery anatomy with CaW angles of 30°, 60°, and 90° (models A, B, and C).

View Article and Find Full Text PDF

The FN1-targeted delivery of low-molecular-weight heparin to venous clots revolutionizes thrombosis treatment in CVT.

Biomaterials

August 2025

Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Capital Medical University, Beijing, 100069, China; Neuro Cardio Vas

The systemic administration of low-molecular-weight heparin (LMWH) as the standard initial treatment for venous thromboembolism is intended to prevent thrombus growth during the acute phase and prevent thrombus recurrence during the chronic phase. However, precisely controlling the specificity and localization of LMWH presents significant challenges, which has necessitated research into targeted delivery methods. Furthermore, due to different thrombosis mechanisms, tailored pharmacologic interventions are needed, particularly for arterial and venous thrombosis.

View Article and Find Full Text PDF

Venous thromboembolism (VTE) remains a significant cause of morbidity and mortality in breast cancer patients, particularly in those with advanced disease or undergoing systemic therapies. While breast cancer is not traditionally classified among the most thrombogenic malignancies, accumulating evidence suggests that tumor biology, treatment modalities, and systemic inflammation can collectively heighten thrombotic risk. This has led to a growing interest in the concept of , wherein the coagulation cascade and inflammatory responses are intricately linked, creating a prothrombotic and tumor-supportive environment.

View Article and Find Full Text PDF

Background: Apixaban and rivaroxaban are oral direct factor Xa inhibitors, primarily eliminated through CYP3A4-mediated metabolism and direct intestinal excretion. Previous studies suggest that palbociclib, a CDK4/6 inhibitor, may increase the systemic exposure of these anticoagulants; however, the specific pharmacokinetic mechanisms remain unclear. This study aims to evaluate the effects of palbociclib on the pharmacokinetics of apixaban and rivaroxaban using a rat model to optimize combined drug regimens.

View Article and Find Full Text PDF